Returns, Reconciliation and Destruction

Clinigen manages returned drug accountability, reconciliation, and destruction for your clinical study; just another reason why working with our team is refreshingly easy and effective.

Moulding our services to meet the exact needs of your clinical study, our capabilities highly surpass those of any other clinical supply service provider. We offer GMP and cGMP compliant procedures and processes, and our own highly-trained team will work with each client to meet protocol-specific needs while additionally ensuring the necessary compliance and safety procedures are met.

Our mission is to professionally and competently manage your clinical supplies through every step of your clinical trial – even if/when changes occur during the process. This means clear and concise communication, especially at the beginning of your clinical study development process. This ensures we are all on the same page in order to mitigate costs, as well as reassure you that we understand that returns can potentially impact the integrity of your study. We are here to make sure that doesn’t happen, but that if it does, we understand the urgency of time.

We recognize your clinical trial team’s initial planning process will inevitably focus on the necessary clinical supplies, clinical trial packaging, and timely delivery of the essential clinical supplies.

The focus is understandably less on later logistics such as the return, reconciliation, and destruction of unused drugs. But by neglecting these action items during the planning process, it can lead to requirement creep and unexpected costs. This is why early dialogue and decisions about returned drug accountability is a crucial, necessary piece of your clinical trial supplies management process.

Choosing the most appropriate system at the start of a clinical study can have a tremendous impact, positively or negatively, on the clinical trial returns process during and at the end of a study. At Clinigen, we value our clients and their successes, and as such, innovation and cost-efficiency are crucial when it comes to accounting for your clinical drug returns, reconciliation, and destruction.

Full Clinical Trial Return, Reconciliation, and Destruction Services:

Success stories

On behalf of my team, I would like to express our sincere thanks to Clinigen for your extraordinary work and dedication. We would not have been able to meet our clinical program goal without your heroic effort.

Vice President of Technical Operations

BioPharma company

Spotlight 1.png

Take 20 minutes and connect with a clinical supplies management expert

As a leading provider on a global scale, Clinigen is committed to delivering fully integrated logistics services to our clients. Over 80% of the studies we are supporting are multi-national and we organise shipments to 130+ countries.

Schedule a call with our experts